Advertisement

Exactech, Inc. EXAC

Set alert

Price alert · EXAC

All alert types
49.25 0.00 0.00%

At close · Jun 28

49.25 Day range 49.25
24.35 52-week range 50.95
Open
49.25
Prev close
49.25
Mkt cap
710.38M
Vol
0
Avg vol
134.36K
EPS
0.026
P/E
1894.23
Div yield
0.00%
More statistics
Low
49.25
High
49.25
Forward P/E
34.93
Beta
0.39
Short ratio
0.45
Inst. own
53.58%
Dividend
0.00
Ex-div date
Earnings
Feb 20, 2018
50-d avg
49.39
200-d avg
42.89
1y target
49.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for EXAC has not been loaded yet. Try again in a moment.

Key statistics

Market cap
710.38M
Enterprise value
710.53M
Trailing P/E
1894.23
Forward P/E
34.93
PEG ratio
0.00
Price / sales
2.69
Price / book
2.83
EPS (TTM)
0.026
Beta
0.39
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.18%
Revenue (TTM)
264.44M
Revenue growth
2.50%
Free cash flow
8.11M
Total cash
11.72M
Total debt
14.00M
Return on equity
0.20%
Shares outstanding
14.42M
Short % of float
2.05%
50-day average
49.39
200-day average
42.89

Analyst view

Consensus: hold

Hold
Price target (mean) 49.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Feb 20, 2018

Expected Feb 20, 2018. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
EXAC Revenue — quarterly 61.40M
2013-Q4 20132014-Q1 20142014-Q2 20142014-Q3 20142014-Q4 20142015-Q1 20152015-Q2 20152015-Q3 20152015-Q4 20152016-Q1 20162016-Q2 20162016-Q3 20162016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 2017
EXAC Net income — quarterly 2.86M
2013-Q4 20132014-Q1 20142014-Q2 20142014-Q3 20142014-Q4 20142015-Q1 20152015-Q2 20152015-Q3 20152015-Q4 20152016-Q1 20162016-Q2 20162016-Q3 20162016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 2017
EXAC EPS — quarterly 0.20
2013-Q4 20132014-Q1 20142014-Q2 20142014-Q3 20142014-Q4 20142015-Q1 20152015-Q2 20152015-Q3 20152015-Q4 20152016-Q1 20162016-Q2 20162016-Q3 20162016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 2017

Earnings

EXAC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 20, 2018Dec 1, 20170.00———
Oct 30, 2017Sep 1, 20170.23———
Jul 27, 2017Jun 1, 20170.33———
Apr 25, 2017Mar 1, 20170.31———
Feb 21, 2017Dec 1, 20160.31———
Oct 31, 2016Sep 1, 20160.22———

Upgrades / downgrades

EXAC analyst upgrades and downgrades
DateFirmActionFromTo
Apr 12, 2016Bairdup—Outperform
May 13, 2015Northland Securitiesinit—Market Perform
Apr 29, 2015Canaccord Genuitydown—Hold
Mar 18, 2015Gabelli & Co.init—Buy
May 17, 2012Benchmarkinit—Buy

About Exactech, Inc.

Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopedic implant devices, related surgical instrumentation, and biologic services. It offers extremities products comprising Equinoxe, a platform shoulder system for the treatment of degenerative disease and trauma; and knee system that provides solutions for partial, primary, and revision total knee arthroplasty. The company also provides hip solutions that address hip arthroplasty, reconstruction, and fractures, as well as primary hip surgeries. In addition, it offers biologics and spine products for the healing and regeneration of bone and soft tissues; and markets a platform of demineralized bone matrix products under the brand name Optecure, as well as OpteMx, a tri-calcium phosphate/hydroxyapatite based synthetic bone graft substitutes. Further, the company provides Accelerate, a platelet concentrating system that offers high platelet yields through centrifugal action; distribute Ossigen, a 3D matrix of collagen and an organic bone mineral processed into blocks for surgical implantation for the repair of bony defects in the spine, extremities, and pelvis; and Ossilix, a calcium phosphate bone cement indicated for filling bony defects in cancellous bone. Additionally, it offers Cemex Genta, a bone cement containing antibiotics; Cemex Fast, a cement with or without antibiotic; the InterSpace hip, knee, and shoulder spacers; and AcuDriver Automated Osteotome System, an air-driven impact handpiece that surgeons use during joint implant revision procedures to remove failed prostheses and bone cement. The company markets its orthopedic implant products through a network of independent sales agencies and distributors, direct sales representatives, and subsidiaries to hospitals, surgeons and other physicians, and clinics in the United States and internationally. Exactech, Inc. was founded in 1985 and is headquartered in Gainesville, Florida.

Sector
Healthcare
Industry
Medical Appliances & Equipment
Country
United States
Website
exac.com

News

Your note

Sign in to keep a note on EXAC — it syncs with the Stock Master app.

Insider holders

EXAC insider holders
InsiderRelationLatest transactionDateShares held
BINCH JAMES GDirectorSaleFeb 13, 20180
EDWARDS DONNA MOfficerSaleFeb 13, 20180
KRUSEN W ANDREW JRDirectorSaleFeb 13, 20180
LOCANDER WILLIAM BDirectorSaleFeb 13, 20180
MILLER GARY JOfficerSaleFeb 13, 20180
PETTY BETTY AOfficerSaleFeb 13, 20180

Institution ownership

EXAC institution ownership
Holder% heldSharesValueReported
Dimensional Fund Advisors LP6.16%888,22844.01MDec 30, 2017
Blackrock Inc.5.95%857,84242.51MDec 30, 2017
Gamco Investors Inc5.30%764,50837.88MDec 30, 2017
Gabelli Funds, LLC4.87%701,74834.77MDec 30, 2017
Water Island Capital, LLC3.75%541,39526.83MDec 30, 2017
Vanguard Group, Inc. (The)3.58%515,73025.55MDec 30, 2017

Fund ownership

EXAC fund ownership
Holder% heldSharesValueReported
EQ Advisors Trust-1290 VT Gamco Small Company Value Port2.08%300,0009.03MJun 29, 2017
DFA U.S. Small Cap Value Series1.73%249,6047.54MJul 30, 2017
iShares Russell 2000 ETF1.50%216,53810.73MDec 30, 2017
Teton Westwood Mighty Mites Fd1.48%213,40010.57MDec 30, 2017
Gabelli Small Cap Growth Fund1.46%210,02410.41MDec 30, 2017
Vanguard Total Stock Market Index Fund1.40%202,0026.08MJun 29, 2017
Advertisement